APA (7th ed.) Citation

A, M., I, A., F, G., KB, S., SM, B., A, T., . . . U, S. (2022). An Fc-inert PD-L1×4-1BB bispecific antibody mediates potent anti-tumor immunity in mice by combining checkpoint inhibition and conditional 4-1BB co-stimulation. Oncoimmunology, 11(1), 2030135. https://doi.org/10.1080/2162402X.2022.2030135

Chicago Style (17th ed.) Citation

A, Muik, et al. "An Fc-inert PD-L1×4-1BB Bispecific Antibody Mediates Potent Anti-tumor Immunity in Mice by Combining Checkpoint Inhibition and Conditional 4-1BB Co-stimulation." Oncoimmunology 11, no. 1 (2022): 2030135. https://doi.org/10.1080/2162402X.2022.2030135.

MLA (9th ed.) Citation

A, Muik, et al. "An Fc-inert PD-L1×4-1BB Bispecific Antibody Mediates Potent Anti-tumor Immunity in Mice by Combining Checkpoint Inhibition and Conditional 4-1BB Co-stimulation." Oncoimmunology, vol. 11, no. 1, 2022, p. 2030135, https://doi.org/10.1080/2162402X.2022.2030135.